Skip to content
BidBenchmark

Contract award

HAWAII BIOTECH, INC.

IGF::OT::IGF - "DEVELOPMENT OF A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS."
PIID
75N93018C00023
Award key
CONT_AWD_75N93018C00023_7529_-NONE-_-NONE-
Recipient UEI
ECJKEEFL4L51
Source as of
Current award value
$24,623,8803
Obligated to date
$24,623,8802
Potential with options
$40,358,9773
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Honolulu, Hawaii
Set-aside
No set-aside used
Pricing
Cost Plus Fixed Fee
Competition
Full and Open Competition24 offers received
Period of performance
Sep 20, 2018Jul 22, 2025Through Jul 22, 2025 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 20, 2018Initial award$12,124,546.00$24,623,880.00
P00001Jul 28, 2019B$2,888,300.00$24,623,880.00
P00002Nov 5, 2019B$0.00$24,623,880.00
P00003Jan 29, 2020B$0.00$24,623,880.00
P00004Apr 8, 2020B$3,958,433.00$24,623,880.00
P00005Jul 1, 2020B$659,542.00$24,623,880.00
P00006Aug 31, 2020G$4,399,101.00$24,623,880.00
P00007Dec 18, 2020B$0.00$24,623,880.00
P00008Jun 7, 2021M$0.00$24,623,880.00
P00009Jun 10, 2021B$0.00$24,623,880.00
P00010Aug 27, 2021B$69,252.00$24,623,880.00
P00011Dec 1, 2021B$0.00$24,623,880.00
P00012Jun 10, 2022M$0.00$24,623,880.00
P00013Jun 22, 2022B$0.00$24,623,880.00
P00014Nov 29, 2022B$0.00$24,623,880.00
P00015Apr 28, 2023B$2,139,810.00$24,623,880.00
P00016Jun 30, 2023C-$207,821.00$24,623,880.00
P00017Sep 6, 2023B$0.00$24,623,880.00
P00018Mar 8, 2024B-$21,379.00$24,623,880.00
P00019Apr 28, 2025B$1,282,644.00$24,623,880.00
P00020Jul 22, 2025F-$2,666,912.00$24,623,880.00
P00021Aug 6, 2026C-$1,636.00$24,623,880.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d21fdd8dc94c
contractor_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d21fdd8dc94c
current_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d21fdd8dc94c
naics_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d21fdd8dc94c
potential_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d21fdd8dc94c
psc_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d21fdd8dc94c
total_obligatedUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2d21fdd8dc94c

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 22 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75N93018C00023 — HAWAII BIOTECH, INC. · BidBenchmark